Ionis Pharmaceuticals (IONS) PT Raised to $86 at Stifel

April 29, 2026 4:10 PM

Stifel analyst Paul Matteis raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $86.00 (from $83.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found